Peripheral Vascular Devices Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Peripheral vascular disease (PVD), also known as arteriosclerosis obliterans, arterial insufficiency of the legs, claudication, or intermittent claudication is a blood circulation disorder that results in the narrowing of blood vessels outside the heart and the brain. It can also block the blood vessels altogether. Peripheral vascular disease can occur in the veins or arteries. The disease usually causes fatigue and pain, often in the legs, and particularly during strenuous physical activities, which usually subsides with rest. PVD can affect the vessels that supply oxygen and blood to arms, kidneys, intestines and stomach. In peripheral vascular disease, blood vessels are narrowed and flow of blood decreases. This can happen due to arteriosclerosis (hardening of the arteries), or it can be caused by spasms in the blood vessel. In case of arteriosclerosis, plaques build up in a blood vessel and hamper the flow of blood and oxygen to the limbs and other organs. As the plaque growth progresses, the artery can get completely blocked due to the formation of clot in the vessels. If left untreated, his phenomenon can result into organ damage, loss of fingers, toes, or limbs. PAD or Peripheral arterial disease is a type of peripheral vascular disease that develops only in the arteries (blood vessels carrying oxygen-rich blood from the heart to the other parts of the body). According to the Center for Disease Control and Prevention, around 12 to 20 percent of the population over the age of 60 developed PAD, in 2016. Peripheral arterial disease is the most common form of peripheral vascular disease

Request Sample Copy of the Business Report:

The number of patients with peripheral artery disease is increasing at a steady rate throughout the world and hence the peripheral vascular devices market is likely to grow at substantial rate over the forecast period. The global market of peripheral vascular devices…

Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *